Evidence map›Paper›PMID 23955078›Full record

ArticleOncogene2014

The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.

C Leufke, J Leykauf, D Krunic, A Jauch, H Holtgreve-Grez, B Böhm-Steuer, E-B Bröcker, C Mauch, J Utikal, W Hartschuh and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

C LeufkeDivision of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
J LeykaufDivision of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
D KrunicDivision of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
A JauchInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
H Holtgreve-Grez1] Division of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany [2] Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
B Böhm-SteuerInstitute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
E-B BröckerDepartment of Dermatology, University of Würzburg, Würzburg, Germany.
C MauchDepartment of Dermatology, University of Köln, Würzburg, Germany.
J UtikalSkin Cancer Unit, German Cancer Research Center Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
W HartschuhDepartment of Dermatology, University of Heidelberg, Heidelberg, Germany.
K J PurdieUK Cancer Research UK Skin Tumour Laboratory, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK.
P BoukampDivision of Genetics of Skin Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DEUniversity of Würzburg · DECancer Research UK · GBUniversity Hospital Heidelberg · DE

Funding

Cancer Research UK 13044
6 · The paper itself

Abstract

The incidence of skin cancer is increasing worldwide and cutaneous squamous cell carcinomas (SCCs) are associated with considerable morbidity and mortality, particularly in immunosuppressed individuals ('carcinomatous catastrophy'). Yet, molecular mechanisms are still insufficiently understood. Besides ultraviolet (UV)-indicative mutations, chromosomal aberrations are prominent. As telomeres are essential in preserving chromosome integrity, and telomere erosion as well as aberrant spatial telomere distribution contribute to genomic instability, we first established telomere length profiles across the whole tissue and identified normal skin (10/30) harboring discrete epidermal sites (stem cell territories) of evenly short telomeres. Precancerous actinic keratoses (AKs) (17) and SCCs (27) expressed two telomere phenotypes: (i) tissue-wide evenly short to intermediate and (ii) longer and tissue-wide heterogeneous telomere lengths, suggesting two modes of initiation, with one likely to originate in the epidermal stem cells. Although tumor histotype, location, patient gender or age failed to distinguish the two SCC telomere phenotypes, as did telomerase activity, we found a trend for a higher degree of aberrant p53 and cyclin D1 expression with long/heterogeneous telomeres. In addition, we established an association for the short/homogeneous telomeres with a simpler and the heterogeneous telomeres with a more complex karyotype correlating also with distinct chromosomal changes. SCCs (13) from renal transplant recipients displayed the same telomere dichotomy, suggesting that both telomere subtypes contribute to 'carcinomatous catastrophy' under immunosuppression by selecting for a common set (3, 9p and 17q) and subtype-specific aberrations (e.g., 6p gain, 13q loss). As a second mechanism of telomere-dependent genomic instability, we investigated changes in telomere distribution with its most severe form of telomeric aggregates (TAs). We identified a telomere length-independent but progression-dependent increase in cells with small telomere associations in AKs (17/17) and additional TAs in SCCs (24/32), basal cell carcinomas (30/31) and malignant melanomas (15/15), and provide evidence for a reactive oxygen species-dependent mechanism in this UV-induced telomere organization-dependent genomic instability.

Indexed as

AdolescentAdultAgedAged, 80 and overCarcinoma, Squamous CellCell Line, TumorChildCyclin D1Disease ProgressionGenomic InstabilityHumansMaleMelanomaMiddle AgedSkin NeoplasmsTelomeraseCyclin D1TelomeraseTumor Suppressor Protein p53

Identifiers

PMID23955078
OpenAlexW2129807135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.